COVID-19 Infection Linked to Increased Risk of Type 1 Diabetes in Young Children
Recent research conducted by the Institute of Diabetes Research in Munich, Germany, has discovered a significant association between COVID-19 infection and the development of type 1 diabetes (T1D) in young children. The study, published in the Journal of Autoimmunity, analyzed the DNA methylation patterns in blood samples from 740 children at risk for T1D, and found that COVID-19 infection was characterized by differential methylation at immune and T1D susceptibility genes. This research suggests that COVID-19 infection may contribute to immune dysregulation and promotion of the autoimmune process underlying T1D.
Key Takeaways:
- The study found that COVID-19 infection was associated with differential methylation at key immune- and antiviral genes, including ADAR, IFI44L, MX1, and OASL.
- Children with recent COVID-19 infection showed sustained DNA methylation changes at genes critical for antiviral response and T1D susceptibility.
- The research suggests that COVID-19 infection may contribute to immune dysregulation and promotion of the autoimmune process underlying T1D.
- Infections with influenza showed no associations with differential methylation at these genes.
- The study involved 740 prospectively followed children with increased risk of T1D, who were monitored for SARS-CoV-2 and influenza A infection from age 6 months to age 1.5 years.
Statistics:
- 81 children had COVID-19 infection prior to the DNA methylation sample.
- 74 children had influenza A infection prior to the DNA methylation sample.
- 43 children had recent COVID-19 infection, defined as infection within 3 months of the DNA methylation sample.
- 22 children had recent influenza A infection.
- DNA methylation changes were observed at key immune- and antiviral genes in children with SARS-CoV-2 infection.
- Methylation changes were sustained in children with SARS-CoV-2 infection.
Sources:
- Institute of Diabetes Research, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Munich, Germany.
- Journal of Autoimmunity, Academic Press Ltd- Elsevier Science Ltd, 24-28 Oval Rd, London NW1 7DX, England.